Forte Biosciences (FBRX) Capital Expenditures (2016 - 2025)
Forte Biosciences (FBRX) posted quarterly Capital Expenditures of $55000.0 for Q3 2025, down 9.84% quarter-over-quarter from $61000.0 in Q1 2025.
Powered by 
Analysis
Forte Biosciences (FBRX) Capital Expenditures (2016 - 2025) Analysis & Trends
Forte Biosciences (FBRX) has reported Capital Expenditures for 7 consecutive years, with $55000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Capital Expenditures changed N/A year-over-year to $55000.0; the TTM figure through Mar 2026 stood at $55000.0 (down 40.22% YoY), while the FY2025 annual figure was $116000.0, up 213.51% from the prior year.
- Capital Expenditures slipped to $55000.0 in Q3 2025 per FBRX's latest filing, from $61000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $61000.0 in Q1 2025 and bottomed at $6000.0 in Q1 2024.
- Historically, Capital Expenditures has averaged $35166.7 across 3 years, with a median of $36000.0 in 2023.
- Annual changes were most pronounced in 2024 — Capital Expenditures jumped 82.35% — and 2025, when it surged 916.67%.
- Forte Biosciences' Capital Expenditures stood at $17000.0 in 2023, then surged by 82.35% to $31000.0 in 2024, then surged by 77.42% to $55000.0 in 2025.
- Business Quant data shows FBRX's Capital Expenditures at $55000.0 in Q3 2025, $61000.0 in Q1 2025, and $31000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 37.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 2.29 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 251.02 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Forte Biosciences | 1.58 Bn | 1.23 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 55,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 41,000.00 |
| Dec 31, 2019 | 89,000.00 |
| Sep 30, 2019 | -184,000.00 |
| Jun 30, 2019 | 124,000.00 |
| Mar 31, 2019 | 133,000.00 |
| Dec 31, 2018 | 472,000.00 |
| Sep 30, 2018 | 619,000.00 |
| Jun 30, 2018 | 657,000.00 |
| Mar 31, 2018 | 220,000.00 |
| Dec 31, 2017 | 318,000.00 |
| Sep 30, 2017 | 179,000.00 |
| Jun 30, 2017 | 105,000.00 |
| Mar 31, 2017 | 53,000.00 |
| Dec 31, 2016 | 10,000.00 |
| Sep 30, 2016 | 160,000.00 |